Poland· PL-100397017
Rifamycin Adalvo
A antibiotics product containing rifamycinum natricum, registered in Poland by Adalvo Competence Center S.R.L.. The same ATC class is registered in 2 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Rifamycinum natricum is registered in 2 of 19 countries.
Countries holding a registration under ATC A07AA (antibiotics), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 2 of them publish a price we can compare per daily dose
Rifamycinum natricum · ATC A07AA
2 / 19 countries
- Polandprice
- United Statesprice
The record
At a glance
URPL (Poland)- Active substance
- Rifamycinum natricum
- Manufacturer
- Adalvo Competence Center S.R.L.
- Country
- Poland (PL)
- ATC code
- A07AA
- ATC class
- Antibiotics
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05909991396473
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Rifamycinum natricum in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainRIFAMICINA ADALVO 200 MG COMPRIMIDOS DE LIBERACION MODIFICADAAdalvo Competence Center S.R.L.
- SwedenRifamycin Adalvo 200 mg Tablett med modifierad frisättningAdalvo Limited
- FranceOTOFA, solution auriculaire en gouttesBOUCHARA-RECORDATI
- ItalyDOTECINE*12 cpr 200 mg rilascio modificatoMALESCI SpA IST.FARMACOBIOL.
- BelgiumRifocine 500 IV 500 mgSanofi Belgium
- FinlandRelafalkAdalvo Competence Center S.R.L.
- GermanyGutiviaLunatus Gmbh
Authorised across Europe · EMA
The same active substance is authorised in 12 EEA countries. Names it is sold under:
- Belgium · Rifocine I.V.
- Bulgaria · Relafalk
- Germany · Gutivia
- Finland · Relafalk
- France · Otofa, Rifamycine Chibret
- Greece · Relafalk
- Hungary · Relafalk
- Italy · Dotecine, Rifocin
- Luxembourg · Otofa, Rifocine I.V.
- Norway · Relafalk
- Portugal · Imfalda, Rifocina
- Sweden · Relafalk
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b3e4e9c9-1c06-4023-b730-7c2aea863055 GET /v1/drugs/b3e4e9c9-1c06-4023-b730-7c2aea863055?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki o zmodyfikowanym uwalnianiu",
"source": "urpl",
"strength": "200 mg",
"packaging": "05909991396473 ¦ Rp ¦ 131563\n12 tabl.",
"substance": "Rifamycin sodium 200 mg",
"common_name": "Rifamycinum natricum",
"pl_product_id": "100397017",
"pozwolenie_nr": "25180",
"auth_procedure": "DCP",
"authorisation_validity": "Bezterminowe"
}See everything about rifamycinum natricum.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.